Casein kinase 1 family proteins promote Slimb-dependent Expanded degradation
Abstract
Hippo signalling integrates diverse stimuli related to epithelial architecture to regulate tissue growth and cell fate decisions. The Hippo kinase cascade represses the growth-promoting transcription co-activator Yorkie. The FERM protein Expanded is one of the main upstream Hippo signalling regulators in Drosophila as it promotes Hippo kinase signalling and directly inhibits Yorkie. To fulfil its function, Expanded is recruited to the plasma membrane by the polarity protein Crumbs. However, Crumbs-mediated recruitment also promotes Expanded turnover via a phosphodegron-mediated interaction with a Slimb/β-TrCP SCF E3 ligase complex. Here, we show that the Casein Kinase 1 (CKI) family is required for Expanded phosphorylation. CKI expression promotes Expanded phosphorylation and interaction with Slimb/β-TrCP. Conversely, CKI depletion in S2 cells impairs Expanded degradation downstream of Crumbs. In wing imaginal discs, CKI loss leads to elevated Expanded and Crumbs levels. Thus, phospho-dependent Expanded turnover ensures a tight coupling of Hippo pathway activity to epithelial architecture.
https://doi.org/10.7554/eLife.46592.001Introduction
The maintenance of epithelial tissue architecture through cell-cell and cell-extracellular matrix contacts, as well as cell polarity, is essential for organ function and size control (Genevet and Tapon, 2011; Low et al., 2014). The evolutionarily conserved Hippo (Hpo) pathway, a key signalling module that senses and responds to epithelial organisation, has emerged as a critical regulator of growth and epithelial integrity (Genevet and Tapon, 2011; Schroeder and Halder, 2012; Yu and Guan, 2013). At the core of Hpo signalling is a kinase cascade comprising Hpo and Warts (Wts), which promote the phosphorylation and inactivation of the pro-growth transcriptional co-activator Yorkie (Yki, YAP in mammals), thereby repressing tissue growth (Yu and Guan, 2013; Fulford et al., 2018; Hong and Guan, 2012). When Hpo signalling is inactive, Yki/YAP is able to enter the nucleus, associate with its transcription factor partner Scalloped (TEAD1-4 in mammals) and promote the expression of cell cycle regulators and apoptosis inhibitors, among others (Genevet and Tapon, 2011; Yu and Guan, 2013; Hong and Guan, 2012). To ensure that epithelial homeostasis is maintained, Yki/YAP also control the expression of Hpo pathway upstream regulators that dampen Yki/YAP activity as part of a negative feedback mechanism (Genevet and Tapon, 2011; Halder and Johnson, 2011).
Yki/YAP activity responds to epithelial organisation through the actin cytoskeleton (Gaspar and Tapon, 2014), basolateral polarity determinants (Chen et al., 2012; Cordenonsi et al., 2011; Grzeschik et al., 2010), adherens junction components, such as α-catenin (Schlegelmilch et al., 2011), and apical polarity proteins, such as Crumbs (Crb) (Grzeschik et al., 2010; Chen et al., 2010; Hafezi et al., 2012; Ling et al., 2010; Robinson et al., 2010; Varelas et al., 2010). While the vast majority of these inputs act through Hpo and/or Wts, some engage core kinase cascade-independent signalling (Genevet and Tapon, 2011; Yu and Guan, 2013). The FERM domain protein Expanded (Ex) is a key regulator of Yki function (Hamaratoglu et al., 2006), which inhibits tissue growth using both Hpo-dependent and -independent mechanisms, in a manner analogous to mammalian Angiomotins (Moleirinho et al., 2014). Ex is an upstream activator of the Hpo core kinase cassette that forms a complex with Kibra and Merlin (Baumgartner et al., 2010; Genevet et al., 2010; McCartney et al., 2000; Yu et al., 2010). Ex has been proposed to promote core kinase activity by bridging Hpo association with the upstream kinase Tao-1 together with Schip1 (Genevet and Tapon, 2011; Chung et al., 2016), and by recruiting Wts to the apical membrane where it can be activated by Hpo (Sun et al., 2015). Ex also restrains tissue growth in a phosphorylation-independent manner by tethering Yki at the apical membrane via a direct PPxY:WW domain-mediated interaction (Badouel et al., 2009; Oh et al., 2009), a process regulated by Ack-dependent tyrosine phosphorylation of Ex (Hu et al., 2016). Moreover, Ex has also been linked with F-actin-mediated regulation of Yki function, by antagonising the action of Zyxin (Gaspar et al., 2015). Interestingly, ex is a Yki target gene and, therefore, it is a prime candidate to mediate the Hpo pathway feedback regulation that controls tissue homeostasis (Genevet and Tapon, 2011; Halder and Johnson, 2011).
Ex is a key link between epithelial polarity and Hpo signalling. This is controlled by the transmembrane protein Crb, which in addition to its recognised role in polarity, also regulates tissue growth by modulating the Notch and Hpo pathways (Grzeschik et al., 2010; Chen et al., 2010; Hafezi et al., 2012; Ling et al., 2010; Robinson et al., 2010; Richardson and Pichaud, 2010). Via its FERM-binding motif (FBM), Crb recruits Ex to the apical membrane, where it can promote inhibition of Yki (Genevet and Tapon, 2011; Chen et al., 2010; Hafezi et al., 2012; Ling et al., 2010; Robinson et al., 2010; Su et al., 2017). However, besides activating Hpo signalling through Ex, Crb also stimulates Ex phosphorylation and turnover of Ex protein (Genevet and Tapon, 2011; Grzeschik et al., 2010; Chen et al., 2010; Ling et al., 2010; Robinson et al., 2010; Ribeiro et al., 2014; Laprise, 2011). We have previously shown that ubiquitylation and degradation of Ex downstream of Crb is mediated by the phospho-dependent SCFSlimb/β-TrCP E3 ligase complex, which is also thought to regulate Ex levels independently of Crb (Ribeiro et al., 2014; Zhang et al., 2015). However, the identity of the kinase(s) that promote Ex degradation downstream of Crb is currently unknown.
Here, we identify the Casein Kinase 1 (CKI) family of protein kinases as regulators of Ex stability that function downstream of the polarity protein Crb. Depletion of CKI kinases suppresses Crb-induced Ex phosphorylation, ubiquitylation and degradation. Interestingly, CKI kinases regulate Ex in a partially redundant manner, which suggests that regulation of Ex stability is a key step in the regulation of Yki function and the maintenance of tissue homeostasis.
Results
Crb promotes interaction of Ex with Casein kinase 1 family proteins
We have previously shown that Crb regulates Ex protein stability in a β-TrCP-dependent manner (Ribeiro et al., 2014). The Ex:Slimb (Slmb, Drosophila β-TrCP) interaction is mediated by a β-TrCP consensus sequence immediately following the Ex N-terminal FERM domain (452TSGIVS457). In agreement with the fact that β-TrCP targets substrates for ubiquitylation and degradation through the recognition of a phosphodegron, Ex is phosphorylated in Drosophila S2 cells in the presence of ectopic Crb (full-length or the intracellular domain, Crbintra) (Ling et al., 2010; Robinson et al., 2010; Ribeiro et al., 2014). However, the kinase(s) involved in Ex degradation downstream of Crb are currently unknown. In our previous report, we used affinity purification coupled with mass spectrometry (AP-MS) to identify Slmb as an Ex interacting protein (Ribeiro et al., 2014). Upon re-analysis of our AP-MS data, we observed that Gilgamesh (Gish), the Drosophila orthologue of Casein kinase 1γ, was specifically purified by an Ex truncation that fully recapitulates the Crb-mediated effect on Ex stability (Ex1-468) (Figure 1A) (Ribeiro et al., 2014). Importantly, Gish peptides were detected in the Ex1-468 AP-MS only upon co-expression with wild-type (wt) Crb but not with a FERM-binding motif mutant version of Crb (ΔFBM) that cannot bind Ex or promote its depletion (Figure 1A) (Ling et al., 2010; Robinson et al., 2010; Ribeiro et al., 2014). In contrast, Hpo interacted with Ex regardless of Crb presence, in agreement with previous reports (Figure 1A) (Yu et al., 2010).
We validated our AP-MS data by performing co-immunoprecipitation (co-IP) analyses in S2 cell lysates. In reciprocal co-IP experiments, an interaction between Gish and Ex1-468 was readily detected in S2 cells, specifically in the presence of wt Crb (Figure 1B–C). The Casein kinase 1 (CKI) protein family includes several members (Jiang, 2017), with high homology in their kinase domains (Figure 1—figure supplement 1A–C), which are thought to, at least in part, share consensus sequences and targets (Knippschild et al., 2014; Schittek and Sinnberg, 2014; Venerando et al., 2014). The Drosophila gish (CKIγ) locus produces multiple protein isoforms, one of which, GishisoF, lacks a conserved C-terminal palmitoylation motif (Figure 1—figure supplement 1B,D), which would be predicted to affect its localisation (Davidson et al., 2005; Li et al., 2016). Therefore, we used two different isoforms of Gish that either contain (GishisoI) or lack (GishisoF) this palmitoylation sequence. Interestingly, only GishisoI, but not GishisoF, was able to interact with Ex (Figure 1B) suggesting that CKI sub-cellular localisation may be critical to the regulation of Ex.
CKI kinases promote Ex phosphorylation and degradation in vitro
The CKI family commonly targets substrates for proteasomal degradation (Knippschild et al., 2014; Schittek and Sinnberg, 2014), prompting us to test if Gish could promote Ex degradation. To this end, we analysed Ex electrophoretic mobility shift and protein levels (indicative of phosphorylation and degradation, respectively) in S2 cells upon expression of different CKI kinases. Co-expression of Ex1-468 and GishisoI in the absence of Crb resulted in a mild depletion of Ex1-468 protein levels (Figure 2A), whereas GishisoF had no effect. We reasoned that the mild effect of GishisoI on Ex stability might be due to relatively low levels of Ex1-468 reaching the membrane in the absence of Crb, which is not endogenously expressed in S2 cells. To mimic the apical membrane localisation of endogenous Ex, we generated an Ex variant containing a C-terminal CAAX sequence (Sotillos et al., 2004), which targets Ex to cellular membranes (Ex1-468 CAAX). Importantly, this variant remains responsive to Crb (Figure 2B), and co-immunoprecipitates with Gish in a Crb-dependent manner (Figure 1C). Ex1-468 CAAX ran mostly as a single band in S2 cells in the presence of the CrbΔFBM mutant and, similar to wt Ex1-468, as a higher mobility band or doublet in the presence of wt Crb (Figure 2A–C). An electrophoretic mobility shift and depletion was also observed when Ex1-468 CAAX was co-expressed with GishisoI, but not with a kinase-dead version of Gish (GishKD) (Figure 2B and Figure 2—figure supplement 1A). Next, we tested whether two other CKI family members, CkIα and Dco (Drosophila CkIδ/ε orthologue), had a similar effect on Ex and whether this effect was dependent on their kinase activity. Indeed, co-expression of Ex1-468 CAAX or full-length (FL) Ex with wt GishisoI, CkIα or Dco led to Ex mobility shift and depletion, although their kinase-deficient (KD) versions did not (Figure 2C and Figure 2—figure supplement 1A–B). Together, these results suggest that multiple CKI family kinases can promote Ex phosphorylation and depletion.
The fact that Ex and Gish interact, and that CKI kinases stimulate Ex degradation in a kinase-dependent manner led us to examine if the CKIs act in the same pathway as Crb and Slmb. To test this, we co-expressed CkIα, Dco or GishisoI in S2 cells with either wt Ex1-468 CAAX or a variant carrying a mutation at S453 (Ex1-468 S453A CAAX), one of the crucial residues that mediates the interaction between Ex and Slmb (Ribeiro et al., 2014). All three kinases readily promoted the degradation of wt Ex1-468 CAAX (Figure 2D). However, the S453A mutant levels were largely unaffected by CKI isoforms, consistent with the notion that the CKI-mediated regulation of Ex stability is dependent on the ability of Ex to interact with Slmb via the phosphodegron surrounding S453. Interestingly, expression of CkIα or GishisoI resulted in the appearance of a slower-migrating Ex1-468 S453A band (Figure 2D). This suggests that, at least for CkIα and Gish, there may be alternative CKI phosphorylation sites in Ex1-468 besides S453.
We also assessed whether CKI kinases could promote the Ex:Slmb interaction, which we have previously shown can be triggered by Crb over-expression (Ribeiro et al., 2014). We found that GishisoI, but not GishisoF, promoted the interaction between Ex1-468 CAAX and Slmb in the absence of ectopic Crb (Figure 2E), consistent with its ability to stimulate Ex mobility shift and depletion. CkIα and Dco were also able to induce binding between Ex1-468 CAAX and Slmb in the absence of Crb (Figure 2—figure supplement 1C). Dco consistently showed a weaker effect on Ex phosphorylation than the other two kinases. Our previous findings showed that the Crb-induced Ex:Slmb interaction relies on the region surrounding the β-TrCP consensus motif (aa 450–468 in Ex) (Ribeiro et al., 2014). Interestingly, an Ex truncation mutant lacking this domain (Ex1-450) was refractory to degradation, and did not display a mobility shift following GishisoI expression (Figure 2—figure supplement 1D), suggesting that CKIs act upstream of Slmb to promote Ex phosphorylation and degradation.
β-TrCP substrates are often targeted for degradation by the sequential action of GSK3β and CKI kinases (e.g. β-catenin) (Gammons and Bienz, 2018). Thus, we tested if the Drosophila GSK3β orthologue Shaggy (Sgg) was involved in the regulation of Ex phosphorylation (Siegfried et al., 1992). However, we found that over-expression of Sgg did not promote Ex:Slmb binding (Figure 2—figure supplement 1E). Moreover, RNAi-mediated depletion of sgg did not abrogate Crb-induced Ex phosphorylation and degradation (Figure 2—figure supplement 1F–G). Together, our results indicate that the CKI kinases, but not Sgg, regulate Ex phosphorylation and stability, acting upstream of Slmb/β-TrCP.
CKI kinases promote Ex phosphorylation and degradation in vivo
Next, we wanted to validate our observations in developing Drosophila tissues. However, assessing Ex protein stability in vivo is complicated by the fact that ex is a Yki target gene (Hamaratoglu et al., 2006) and, therefore, its steady state protein levels reflect not only direct post-translational effects but also transcriptional inputs via the modulation of Hpo signalling. To directly study Ex stability in the absence of any confounding effects due to Yki-mediated transcriptional feedback, we generated transgenic flies carrying an Ex stability reporter construct consisting of Ex1-468 fused to GFP, whose expression is controlled by the ubiquitin 63E promoter rather than its endogenous promoter (ubi-Ex1-468::GFP). We also generated a mutant version that is refractory to Crb-induced degradation by mutating Ser 453, which mediates binding to Slmb (Ribeiro et al., 2014). As predicted, the ubi-Ex1-468::GFP reporters resemble endogenous Ex in that they are normally localised at the apical cortex of wing imaginal disc cells (Figure 3A,B,D,F and Figure 3—figure supplement 1A–B). Importantly, the in vivo reporters recapitulate the effect of Crb on Ex protein stability and localisation. In agreement with previous observations of ExFL, ubi-Ex1-468::GFP failed to localise to the apical surface in crb mutant tissue (Figure 3A–A’ and Figure 3—figure supplement 1A) and accumulated at the apical cortex in slmb mutant clones (Figure 3B–B’ and Figure 3—figure supplement 1B) (Chen et al., 2010; Hafezi et al., 2012; Ling et al., 2010; Robinson et al., 2010; Ribeiro et al., 2014). Loss of both crb and slmb led to accumulation of Ex1-468::GFP in the cytoplasm (Figure 3C–C’), suggesting that the Ex sensor can be degraded by SCFSlimb/β-TrCP in the cytoplasm, as had been suggested for endogenous Ex (Zhang et al., 2015). When a Crbintra transgene was expressed in the posterior compartment using the hedgehog-Gal4 driver (hh-Gal4), ubi-Ex1-468::GFP was lost from the apical surface and degraded (Figure 3D–E and Figure 3—figure supplement 1C). In contrast, the S453A mutant reporter accumulated upon Crbintra expression, presumably due to the fact that it cannot be recognised by Slmb and degraded (Figure 3F–G and Figure 3—figure supplement 1D). This re-localisation of Ex1-468 S453A mirrored the localisation of over-expressed Crbintra, which localised to the apical cortex as well as basal membranes (Figure 3—figure supplement 1E). It is therefore possible that Ex1-468 S453A is mislocalised to the basolateral membrane by ectopic Crb, where it cannot be degraded. A further advantage of using this N-terminal fragment as a reporter is that our constructs lack the Yki-binding PPxY motifs, and therefore, do not induce cell death and reduced tissue growth, as does full length Ex (Hamaratoglu et al., 2006; Badouel et al., 2009; Oh et al., 2009). Indeed, neither reporter affected wing size when expressed at low levels under the control of the ubi promoter (Figure 3—figure supplement 1F–I). In contrast, expression of full-length Ex under the control of en-Gal4 driver induced a reduction in tissue size (Figure 3—figure supplement 1J,L,P). This phenotype was partially rescued by co-expression of Crbintra, which we expect would promote increased turnover and degradation of Ex (Figure 3—figure supplement 1M,P). Interestingly, expression of the S453A mutant version of Ex resulted in a more severe undergrowth than wt Ex, and this was refractory to Crbintra co-expression, suggesting that Crb fails to regulate the levels of Ex when the residue that is recognised by Slmb/β-TrCP is mutated (Figure 3—figure supplement 1N–P).
-
Figure 3—source data 1
- https://doi.org/10.7554/eLife.46592.010
We then analysed whether CKI over-expression could modulate levels of the Ex reporter. Indeed, when compared to control wing discs, expression of CkIα or Gish using hh-Gal4 resulted in a significant decrease in the levels of the reporter in the posterior compartment (Figure 3H–3K). This is consistent with our S2 cell results, and suggests that the CKI family kinases regulate Ex stability in vivo. However, this effect on Ex levels was not seen upon over-expression of either Dco or the poorly characterised CKI family member CG7094 (Figure 3K), indicating that not all CKIs modulate Ex stability in vivo. Importantly, the effect of CKIs on Ex is not due to changes in Crb levels (Figure 3—figure supplement 1Q), and is dependent on kinase activity, since a GishisoI kinase-deficient construct could not alter reporter levels (Figure 3K). In contrast, over-expression of CKIs did not alter the levels of the S453A mutant reporter (Figure 3—figure supplement 1R), providing further evidence that CKIs regulate Ex in a Slmb/β-TrCP-dependent manner.
CKI loss-of-function promotes stabilisation of Ex in vitro
Next, we sought to analyse loss-of-function phenotypes of the CKI kinases. Upon treatment of S2 cells with gish RNAi, Crbintra-mediated depletion of both Ex1-468 and ExFL was strongly reduced (Figure 4A–B and Figure 4—figure supplement 1A). We also attempted to deplete the other CKI kinases by RNAi. However, we were unable to generate a dsRNA that specifically targeted dco (Figure 4—figure supplement 1B). To overcome this, we used RNAi sequences that targeted only ckIα ("ckIα”) or all CKIs (ckIα, dco and gish, termed "ckIpan", previously used in Liu et al. (2002) (Figure 4—figure supplement 1B). In line with our previous data, knockdown of ckIα or gish alone resulted in robust stabilisation of Ex1-468 in the presence of Crbintra (Figure 4C). It is noteworthy that depleting all CKIs resulted in a more prominent stabilisation of Ex1-468, suggesting that CkIα and Gish work together to regulate Ex stability (Figure 4C).
As the CKI kinases appear to act downstream of Crb to regulate Ex stability, we also assessed if their depletion could affect the ability of Crb to promote Ex:Slmb binding and, consequently, Slmb-mediated Ex ubiquitylation and degradation. Indeed, the interaction between Ex and Slmb was abolished when gish or when all CKIs were depleted by RNAi (Figure 4D). When we monitored Crb-induced Ex ubiquitylation, we observed that this was dramatically reduced when gish or all CKIs were depleted by RNAi (Figure 4E–F). Indeed, knocking-down CKIs had a similar effect to depletion of slmb, part of the Ex E3 ligase complex activated downstream of Crb (Figure 4E). These data suggest that CKI kinases act downstream of Crb to promote the interaction of Ex with Slmb, thereby stimulating Ex ubiquitylation and degradation.
Phosphorylation of Crb by aPKC has been proposed to influence its function and, therefore might contribute to the regulation of Ex (Ribeiro et al., 2014; Sotillos et al., 2004). To test this, we compared the effect of wt Crb to that of a variant of Crb containing point mutations in the putative aPKC phosphorylation sites (Crb4A mut). Similar to wt Crb, Crb4A mut efficiently promoted Ex degradation (Figure 4—figure supplement 1C), suggesting that aPKC phosphorylation is not required for the regulation of Ex downstream of Crb. A previous report has shown that, in addition to the N-terminal Slmb/β-TrCP degron, there is a C-terminal degron in Ex, which is inhibited by Wts-mediated phosphorylation (Zhang et al., 2015). To investigate whether Wts plays a role in Crb-mediated Ex degradation, we co-expressed ExFL with either CrbFL or Crbintra, in the presence or absence of ectopic Wts (Figure 4—figure supplement 1D). Though our data confirm that Wts can stabilise ExFL, we observed that the presence of Wts did not prevent the degradation of Ex mediated by the expression of Crb, indicating that the N-terminal degron supersedes the C-terminal one when Crb triggers Ex degradation (Figure 4—figure supplement 1D).
Clonal analysis of CKI mutants
As CKI loss-of-function in S2 cells resulted in Ex stabilisation, we next aimed to validate these observations in vivo. When we assessed the levels of the ubi-Ex1-468::GFP reporter in third instar wing imaginal discs carrying clones mutant for existing gish (gishKG03891) or dco (dcole88) alleles, we observed no differences from control cells, suggesting that these kinases are not essential for maintaining Ex levels at steady state in vivo (Figure 5A and Figure 5—figure supplement 1A). We observed occasional gishKG03891 adult escapers, leading us to hypothesise that this allele is hypomorphic. Therefore, we generated a new gish mutant (bearing a premature termination codon at the N-terminal part of the kinase domain), as well as a mutant for the poorly characterised CKI family member CG7094, which is also expressed in imaginal discs (Brown et al., 2014) using CRISPR/Cas9 gene editing (Figure 5—figure supplement 1B–C). However, when we generated FRT clones for these new alleles, neither caused a change in ubi-Ex1-468::GFP levels compared to wt tissue (Figure 5B and Figure 5—figure supplement 1D). In contrast, we observed that the ubi-Ex1-468::GFP reporter was elevated in ckIα8B12 clones (Figure 5C). We noticed that apical levels of Crb were also increased in ckIα8B12 clones (Figure 5—figure supplement 1E). This was not due to a general increase in apical domain size, since levels of another apical protein, aPKC, did not increase in ckIα8B12 clones (Figure 5—figure supplement 1F–G).
It is possible that the increase in Ex levels in ckIα8B12 clones is the result of an increase in Crb within the clones, causing enhanced recruitment of Ex to the apical cortex, rather than an effect on Ex stability. Alternatively, increased Ex levels as a result of its stabilisation in ckIα8B12 clones might in turn lead to increased membrane retention or stabilisation of Crb. If this were the case, increasing Ex dosage should increase Crb levels. Indeed, over-expression of UAS-Ex1-468 led to a robust increase in endogenous Crb at the apical membrane (Figure 5D). We had previously reported that clones mutant for the hypomorphic allele slmb1 showed elevated levels of Ex, but not Crb (Ribeiro et al., 2014). However, upon careful examination, we were able to detect increased Crb levels in slmb1 clones, albeit mainly when these clones were large (Figure 5E). Furthermore, mutant clones for a null allele, slmb9H4-17, displayed a clear increase in Crb levels (Figure 5F). Thus, both slmb and ckIα mutant clones display elevated levels of Ex and Crb.
Since our S2 cell data suggested that several members of the CKI family may regulate Ex redundantly (Figure 4C), we generated triple mutant clones lacking CG7094, gish and dco, but these did not have altered levels of the Ex1-468::GFP reporter (Figure 5—figure supplement 1H). Triple mutant clones for ckIα, gish and dco had elevated Ex and Crb levels (Figure 5—figure supplement 1I), but these were comparable to ckIα clones alone (Figure 5C and Figure 5—figure supplement 1E–F). Thus, in vivo, it does not appear that CKI family members function redundantly to control Ex levels, at least in wing discs under normal developmental conditions. To test whether the regulation of Ex levels by Slmb and CkIα occurs in tissues other than the wing disc, we generated mutant clones in the eye, leg and haltere imaginal discs (Figure 5—figure supplement 2). In the eye disc, loss of either slmb (Figure 5—figure supplement 2A–A’) or ckIα (Figure 5—figure supplement 2D–D’) led to a strong clone extrusion phenotype and a loss of ommatidial differentiation posterior to the morphogenetic furrow. We did not observe a strong elevation of the Ex::GFP reporter in these mutant clones. However, as the Ex::GFP signal was most prominent in the apical domain of the ommatidial units, it is difficult to conclude if Slmb and CkIα regulate Ex stability in the absence of differentiated ommatidia in the mutant tissue. In contrast, Ex::GFP levels were elevated in both slmb (Figure 5—figure supplement 2B–C’) or ckIα (Figure 6E–6F’) mutant clones in the leg and haltere discs. The requirement for Slmb and CkIα to regulate Ex levels therefore varies according to the tissue.
In S2 cells, depletion of gish or ckIα resulted in Ex stabilisation in the presence of Crb (Figure 4A–C). We hypothesised that over-expressing Crb in vivo would accelerate Ex turnover, thereby providing a sensitised background to examine the effects of CKI depletion. To circumvent the pleiotropic effects of long-term knockdown in imaginal disc epithelial cells, we expressed ckIαRNAi or gishRNAi in the absence or presence of Crbintra using hh-Gal4, and controlled the expression temporally (for 24 hr or 48 hr) using tub-Gal80ts (Figure 6). Quantifications for these data are presented in Figure 6—figure supplement 1B. Expression of Crbintra caused depletion of all apical ubi-Ex1-468::GFP in the posterior compartment within 24 hr (Figure 6—figure supplement 1A). Expression of either ckIαRNAi (Figure 6A–B) or gishRNAi (Figure 6E–F) alone had little effect on ubi-Ex1-468::GFP expression in the posterior compartment (Figure 6—figure supplement 1B). However, co-expression of ckIαRNAi (Figure 6C–D), but not gishRNAi (Figure 6G–H), with Crbintra resulted in a significant rescue of levels and localisation of the ubi-Ex1-468::GFP reporter compared to Crbintra alone (Figure 6—figure supplement 1A–B). Thus, ckIα knockdown, but not gish knockdown, is able to inhibit Crb-mediated Ex degradation in vivo. dcoRNAi had no effect on Ex::GFP reporter levels in the absence (Figure 6—figure supplement 1C), or presence of Crbintra (Figure 6—figure supplement 1D). We confirmed these findings using the MARCM technique, and observed that Crbintra-expressing, GFP-marked MARCM clones caused complete loss of apical ubi-Ex1-468::mScarlet (Figure 6—figure supplement 1E,G). gish MARCM clones expressing Crbintra resembled Crbintra MARCM clones alone (loss of the apical Ex reporter) (Figure 6—figure supplement 1F). In contrast, removing ckIα resulted in a partial rescue of Crb-induced Ex degradation, with a proportion of mutant cells retaining ubi-Ex1-468::mScarlet apically (Figure 6—figure supplement 1H). Together, these results suggest that, in vivo, CkIα regulates Ex stability by promoting Crb-induced turnover.
An increase in Ex stability at the apical plasma membrane would be expected to lead to decreased Yki activity upon ckIα loss (Fulford et al., 2018). In fact, slmb depletion in the posterior wing disc leads to downregulation of the Yki transcriptional reporter ex-lacZ and increased Yki nuclear exclusion (Zhang et al., 2015). Levels of both ex-lacZ and diap1-GFP3.5, a Yki-responsive fragment of the diap1 promoter (Zhang et al., 2008) were markedly decreased in ckIα mutant wing disc clones (Figure 7A,C), while ex-lacZ was not affected in gish mutant tissue (Figure 7B). Furthermore, we used a Yki-GFP knock-in line (Fletcher et al., 2018) to show that Yki is excluded from the nucleus in ckIα mutant cells compared with neighbouring wild type tissue (Figure 7D). Finally, overexpression of CkIα, but not Gish, in the posterior compartment of the wing disc increased Yki activity as measured by ex-lacZ levels (Figure 7E–H). Thus, loss of ckIα leads to Ex stabilisation correlated with decreased Yki activity, while its overexpression has the opposite effect, consistent with a role for CkIα in promoting Yki activity via the control of Ex stability.
-
Figure 7—source data 1
- https://doi.org/10.7554/eLife.46592.021
Discussion
Ex was one of the first identified upstream regulators of the Hippo pathway (Hamaratoglu et al., 2006) and functions as a growth suppressor in Drosophila (Fulford et al., 2018). In agreement with its key role in growth control, it is increasingly evident that Ex is tightly regulated, both at the transcriptional level via Yki itself (Hamaratoglu et al., 2006) and through its subcellular localisation and stability (Chen et al., 2010; Ling et al., 2010; Robinson et al., 2010; Su et al., 2017; Ribeiro et al., 2014; Zhang et al., 2015; Ma et al., 2017). Crb recruits Ex to its site of activity at the apical plasma membrane, but also limits its apical levels by triggering Ex turnover via Slmb/β-TrCP, ensuring the fine-tuning of Yki activity (Chen et al., 2010; Ling et al., 2010; Robinson et al., 2010; Ribeiro et al., 2014; Zhang et al., 2015). Slmb can also promote the degradation of Ex in the cytoplasm in a Crb-independent manner (Zhang et al., 2015, Figure 3C and C’). Another ubiquitin ligase, Plenty of SH3s (POSH) has also been implicated in Ex degradation in parallel to Slmb (Ma et al., 2018). Since our data indicate that Ex levels are not sensitive to Slmb in the eye imaginal disc (Figure 5—figure supplement 2), it is possible POSH is the dominant Ex regulator in this tissue. Interestingly, recent work indicates that the Fat atypical cadherin, a major upstream branch of Hippo signalling (Bennett and Harvey, 2006; Cho et al., 2006; Silva et al., 2006; Willecke et al., 2006) also influences Ex stability by apically recruiting the adaptor Dlish/Vamana (Misra and Irvine, 2016; Wang et al., 2019; Zhang et al., 2016). Dlish binds the Ex C-terminus via its SH3 domain and promotes the Slmb:Ex association, thereby increasing Ex turnover (Wang et al., 2019). Thus, Ex functions as a hub in Hippo signalling that receives input from both the Crb and the Fat branches of upstream signalling.
However, recognition by Slmb/β-TrCP requires substrate phosphorylation, which had remained an unexplored aspect of Ex regulation. Here, we provide evidence that the CKI family of kinases and, in particular, CkIα and Gish, act downstream of Crb to promote phosphorylation of Ex, in turn allowing binding to Slmb/β-TrCP and Ex ubiquitylation and degradation. In conditions whereby Crb-mediated turnover of Ex is active, such as through Crbintra expression, loss of ckIα (and gish in cell culture) inhibited Ex degradation (Figure 4A–C and Figure 6C–D). In the absence of CKI function, Crb is unable to trigger Ex:Slmb binding and thus can no longer induce Ex degradation (Figure 4D–F). In agreement with the requirement for Slmb/β-TrCP function, Ex degradation is dependent on phosphorylation and the presence of a β-TrCP consensus site (452TSGIVS457), which is phosphorylated to allow the interaction to occur (Ribeiro et al., 2014). Our data indicate that CKIs mediate Ex phosphorylation downstream of Crb, as the effect of CKIs on Ex stability is dependent on their kinase activity (Figure 2B–C, Figure 2—figure supplement 1A–B and Figure 3K) and mutation of a conserved residue in the Slmb/β-TrCP consensus (S453A) rendered Ex insensitive to degradation induced by Crb, CKIs or Slmb (Ribeiro et al., 2014) (Figures 3G and 2D). Interestingly, CkIα and Gish were still able to induce a mobility shift in Ex when the S453 residue was mutated (Figure 2D), suggesting that other residues besides S453 may be targets of CKI-mediated phosphorylation. An Ex truncation lacking residues 450–468 (Ex1-450) fails to undergo a mobility shift in the presence of Crbintra or Gish (Figure 2—figure supplement 1D). This may indicate that the additional residues targeted by CKI are in this region, or simply that CKI needs these residues to dock onto Ex.
It remains to be determined whether phosphorylation at additional sites besides S453 is required to promote Ex:Slmb binding, and whether CKIs are part of a phospho-priming mechanism that involves additional kinases, as commonly seen for other CKI targets, such as β-catenin downstream of Wnt signalling (Liu et al., 2002; Amit et al., 2002; Jiang and Struhl, 1998; Stamos and Weis, 2013; Winston et al., 1999). In the case of β-catenin, CK1α acts as a priming kinase for GSK3β/Sgg; however, our data suggest that Sgg does not affect Ex stability (Figure 2—figure supplement 1E–G). Wts/LATS is another candidate, since mammalian LATS1/2 act as priming kinases for CK1δ/ε to target YAP for degradation by SCFβ-TrCP(Zhao et al., 2010). However, Wts has been suggested to stabilise Ex through phosphorylation at S1116, rather than promote its degradation (Zhang et al., 2015). Furthermore, Crb-dependent Ex degradation appears to override Wts-mediated stabilisation (Zhang et al., 2015 and Figure 4—figure supplement 1D). The potential involvement of other kinases in Ex/Slmb binding therefore remains an open question.
An unexpected aspect of our results is the fact that, in cultured S2 cells, Gish (CKIγ) depletion has a strong effect on Ex stability (Figure 4A–C), while CkIα appears to be the dominant player in the wing imaginal disc, both in the presence (Figure 6C–D) and absence (Figure 5C) of Crbintra expression. This is surprising, since Crb-induced Ex phosphorylation and ubiquitylation presumably occurs at the apical plasma membrane, where Gish is known to be localised (Morin et al., 2001). This is unlikely to be due to a lack of Gish activity, since it is implicated in several signalling pathways in the wing disc (Li et al., 2016; Gault et al., 2012). However, CKI isoforms are known to exist in distinct subcellular pools associated with components of the signalling pathways they regulate (Jiang, 2017; Knippschild et al., 2014). It is therefore possible that recruitment of CkIα to Crb/Ex may involve an adaptor protein expressed in the wing disc, as is the case for CkIε, which requires the DEAD-box RNA helicase DDX3 to phosphorylate Dishevelled2 in the mammalian Wnt pathway (Cruciat et al., 2013).
As Ex apical accumulation is predicted to antagonise Yki, we measured several readouts of Yki-dependent transcription and found that Yki activity is indeed decreased upon ckIα depletion and increased by CkIα overexpression, while Gish manipulations had no such effect (Figure 7A–C,E–H). ckIα mutations would therefore be predicted to reduce tissue growth by reducing Yki activity. However, we observed that ckIα mutant clones are generally overgrown, round, and tend to delaminate from the wing disc epithelium, so that they often do not contribute to the adult wing (Figure 5C and Figure 7A,C). This overgrowth phenotype is due to a strong elevation of Wingless (Wg) signalling in ckIα mutant tissue (Legent et al., 2012) and is very similar to the loss of two Wg antagonists, axin and APC1/2 (Adenomatous Polyposis Coli) (Muñoz-Descalzo et al., 2011). Thus, it is likely that the decreased growth occurring as a result of partial loss of Yki activity in ckIα mutant clones is compensated by a strong increase in Wg signalling.
Our data also revealed that loss of either ckIα or slmb function results in an increase in the apical levels of Crb as well as Ex (Figure 5E–F and Figure 5—figure supplement 1E). This is not due to a general increase in apical domain size, since aPKC is not affected (Figure 5—figure supplement 1F–G). These observations raise two possibilities; either that Crb stability is regulated by the same mechanism as Ex, or that Crb and Ex can affect each other’s apical localisation. It seems unlikely that Crb is co-degraded with Ex in a Slmb/β-TrCP-dependent manner, since Crb lacks clear β-TrCP and CKI consensus sequences in its intracellular domain. Moreover, it has been previously shown that Crb levels increase in ex mutant clones (Chen et al., 2010), a result not easily reconcilable with co-degradation. Instead, we favour the second possibility, in which excess Ex accumulation leads to increased Crb apical levels. Consistent with this idea, over-expression of Ex1-468 leads to a robust increase in apical Crb (Figure 5D). Apical Crb endocytosis occurs through docking of the AP-2 (adaptor-protein 2) complex member α-adaptin, which competes with Stardust to bind the Crb intracellular domain (Lin et al., 2015). It is therefore possible that excess Ex interferes with Crb recognition by α-adaptin, thereby decreasing Crb internalisation rates in ckIα or slmb mutant clones.
CRB3, the mammalian orthologue of Crb, can regulate Hippo signalling by mechanisms analogous to those described in Drosophila. CRB3 interacts with two proposed orthologues of Ex, Angiomotin (AMOT), and FRMD6, in a density-dependent manner (Varelas et al., 2010; Angus et al., 2012; Mao et al., 2018; Moleirinho et al., 2013). It would therefore be interesting to test if the stability of either AMOT or FRMD6 is regulated by CRB3, CKI and β-TrCP. In summary, our data support a model whereby the apical polarity determinant Crb promotes Ex phosphorylation by CKI family kinases, which in turn stimulates Slmb/β-TrCP-mediated ubiquitylation and degradation. We propose that this mechanism facilitates precise and dynamic control of Ex protein levels at the apical membrane, which is crucial for the regulation of Hippo signalling.
Materials and methods
Drosophila cell culture, expression constructs and chemical treatments
Request a detailed protocolWork involved the use of the Drosophila cell line Schneider S2 (RRID:CVCL_Z232). Cells were obtained from the ATCC and mycoplasma testing revealed no contaminations. Drosophila S2 cells were grown in Drosophila Schneider’s medium (Thermo Fisher Scientific) supplemented with 10% (v/v) FBS, 50 μg/mL penicillin and 50 μg/mL streptomycin. Expression plasmids were transfected using Effectene transfection reagent (QIAGEN). Expression plasmids were generated using Gateway technology (Thermo Fisher Scientific). ORFs were PCR amplified from cDNA clones obtained from the Drosophila Genomics Resource Center (DGRC, https://dgrc.cgb.indiana.edu/vectors/Overview) and cloned into Entry vectors (pDONR207, pDONR-Zeo). Vectors from the Drosophila Gateway Vector Collection and an in-house V5 tag expression vector were used as destination vectors (Ribeiro et al., 2014). All Entry vectors were verified by sequencing. Point mutations were generated using the Quikchange Site-Directed Mutagenesis kit (Agilent). The Ex full length, Ex1-468 and Crbintra plasmids were previously described (Ling et al., 2010; Genevet et al., 2010; Ribeiro et al., 2014). The WT and mutant versions of Crb differ by specific amino acid substitutions in its intracellular portion (Y10P12E16 to A10A12A16) (Ling et al., 2010). The NTAN-FLAG (N-terminal amidohydrolase 1, an enzyme from the N-end rule pathway that associates with a small number of proteins in Drosophila S2 cells), HA-ubiquitin and Crb4A mut plasmids were kind gifts from M. Ditzel (University of Edinburgh, Edinburgh), P. Meier (Institute for Cancer Research, London) and B. Thompson (Francis Crick Institute, London), respectively. mScarlet (85042; RRID:Addgene_85042) and pCFD3 (49410; RRID:Addgene_49410) plasmids were obtained from Addgene. Where indicated, proteasome inhibition was achieved by treating cells with 50 μM MG132 (Cambridge Bioscience) and 50 μM calpain inhibitor I (Ac-LLnL-CHO or LLnL) (Sigma) for 4 hr before cell lysis or with 5 μM MG132 overnight.
RNAi production and treatment dsRNAs were synthesised using the Megascript T7 kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. DNA templates for dsRNA synthesis were PCR amplified from genomic DNA or plasmids encoding the respective genes using primers containing the 5’ T7 RNA polymerase-binding site sequence. dsRNA primers were designed using the DKFZ RNAi design tool (http://www.dkfz.de/signaling2/e-rnai/). The following primers were used: lacZ (Fwd –TTGCCGGGAAGCTAGAGTAA and Rev – GCCTTCCTGTTTTTGCTCAC); gish (Fwd – TGGCCAAAGAATACATTGATTTAGA and Rev – GGCAGTGAACCCCTTAAGAAATAC); ckIα (Fwd – GGAGTGCATCAGAGAAGGAGAAC and Rev – GTGGGTGTGTTATGCAAGTATGTT); ckIpan (Fwd – GAATTAATACGACTCACTATAGGGAGAGGCCATCAAGATGGAGAGC and Rev – GAATTAATAC GACTCACTATAGGGAGACATGTAATCTGGCTGCTCC) (Liu et al., 2002); dco (Fwd – ACGCAGGCATTTAATTCTGTTT and Rev – GGTGTCCTTTGTTTCTTTTACACA); slmb (Fwd – TGTACTGTAGGCAGGCGATG and Rev – AGGTGATCATCAGTGGCTCC); sgg24 (Fwd – AGCTCTCAATACAGCCCAGC and Rev – CGGTTCCTGCTGTTGCTC); sgg25 (Fwd – CCGCAATTTCAAAAGAACTC and Rev – AAAATGACAATCGATCAGCG). After cell seeding, S2 cells were incubated with 15–20 μg dsRNA for 1 hr in serum-free medium, before complete medium was added. 72 hr after dsRNA treatment, cells were lysed and processed as detailed below.
Immunoprecipitation and immunoblot analysis
Request a detailed protocolFor purification of FLAG-tagged proteins, cells were lysed in lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% Triton X-100, 10% (v/v) glycerol, and 1 mM EDTA), to which 0.1M NaF, phosphatase inhibitors 2 and 3 (Sigma) and protease inhibitor cocktail (Complete, Roche) were added. Cell extracts were spun at 17,000 g for 10 min at 4°C. FLAG-tagged proteins were purified using anti-FLAG M2 Affinity agarose gel (Sigma) for >1 hr at 4°C. FLAG immunoprecipitates were then washed four times with lysis buffer before elution using 150 ng/μl 3x FLAG peptide for 15–30 min at 4°C. For isolation of ubiquitylated proteins, cells were collected by centrifugation and washed with cold PBS. 10% of cell material was lysed as described above. The remaining 90% was lysed with boiling 1% SDS-PBS for 5 min. Following quick vortexing, samples were incubated for 5 min at 100°C before 5-fold dilution using 0.5% BSA-1% Triton X-100-PBS. DNA was sheared by sonication and cell extracts were cleared by centrifugation at 17,000 g for 10 min at 4°C. Samples were diluted 2-fold with 0.5% BSA-1% Triton-X-100-PBS and incubated overnight at 4°C with monoclonal anti-HA agarose beads (Sigma) using Bio-Spin Columns (Bio-Rad). Following incubation, samples were washed with 0.5% BSA-1% Triton-X-100-PBS and 1% Triton X-100-PBS before elution. HA immunoprecipitates were eluted from HA beads using 0.2 M glycine pH 2.5 for 30 min at room temperature and eluted samples were equilibrated with 1 M NH4HCO3. Detection of purified proteins and associated complexes was performed by immunoblot analysis using chemiluminescence (Thermo Fisher Scientific). Western blots were probed with mouse anti-FLAG (M2; Sigma; RRID:AB_262044), mouse anti-Myc (9E10; Santa Cruz Biotechnology; RRID:AB_262044), rat anti-HA (3F10; Roche Applied Science; RRID:AB_2314622), mouse anti-V5 (Thermo Fisher Scientific; RRID:AB_2556564), mouse anti-Crb (Cq4; Developmental Studies Hybridoma Bank, DSHB; RRID:AB_528181), or mouse anti-tubulin (E7; DSHB; RRID:AB_528499). For densitometry analysis of immunoblots, X-ray blots were scanned using an Epson Perfection V700 flatbed scanner and further analysed with the Gel Analyzer function on ImageJ (RRID:SCR_003070). Relative Ex protein levels (normalised to the respective tubulin loading control) were represented as a ratio to the average of the Ex levels in the CrbΔFBM negative control samples.
Immunostaining
Request a detailed protocolLarval tissues were processed as previously described (Genevet et al., 2010). Primary antibodies were incubated overnight at 4°C unless otherwise stated. Rat anti-Ci155 antibody (2A1; DSHB; RRID:AB_2109711) was used at 1:50 or 1:100, chicken anti-GFP (ab13970; Abcam; RRID:AB_300798) was used at 1:1000, rat anti-Crb-ICD (a kind gift from F. Pichaud) was used at 1:200, rabbit anti-aPKC (sc-216, Santa Cruz; RRID:AB_2300359) was used at 1:500, and mouse anti-β-galactosidase (Z3781, Promega; RRID:AB_430877) was used at 1:500. Anti-mouse, anti-rat and anti-rabbit Rhodamine Red-X-, FITC-, or Cy5-conjugated (Jackson ImmunoResearch) secondary antibodies were used at 1:400 or 1:500. Anti-rat Alexa Fluor 488-conjugated secondary antibody (Thermo Fisher) was used at 1:500. Anti-rat Alexa Fluor 568-conjugated (Abcam), anti-chicken Alexa Fluor 488-conjugated (Abcam) or anti-mouse Alexa Fluor 647-conjugated (Jackson ImmunoResearch) secondary antibodies were used at 1:1000. Secondary antibodies were incubated for at least 2 hr at room temperature. After washes, tissues were mounted in Vectashield (with or without DAPI) (H-1000 or H-1200, Vector Labs; RRID:AB_2336789 and RRID:AB_2336790, respectively), or stained with DAPI (1 μg/mL) for 10 min before mounting with Mowiol 40–88 (Sigma). Fluorescence images were acquired on Zeiss LSM510 Meta, Zeiss LSM710 or Zeiss LSM880 confocal laser scanning microscopes (40x objective lens).
Protein sequence alignments
Request a detailed protocolCKI kinases were compiled with BLAST (NCBI; RRID:SCR_004870) using the full-length Drosophila CkIα sequence as query. Sequence alignments were performed using MUSCLE (RRID:SCR_011812) (Edgar, 2004) and CKI kinase phylogeny was designed using the PhyML (RRID:SCR_014629) and DrawTree tools in the Phylogeny online tool (http://www.phylogeny.fr/simple_phylogeny.cgi) (Dereeper et al., 2008). Protein sequence accession numbers were as follows: NP_727631 (D. melanogaster CkIα); NP_001020276.1 (H. sapiens CKIα); NP_733414 (D. melanogaster Dco); NP_001884.2 (H. sapiens CKIδ); NP_001885.1 (H. sapiens CKIε); NP_001163628 (D. melanogaster Gish isoform I); NP_001014628 (D. melanogaster Gish isoform F); NP_071331.2 (H. sapiens CKIγ isoform 1); NP_001310.3 (H. sapiens CKIγ isoform 2); NP_004375.2 (H. sapiens CKIγ isoform 3); NP_572794 (D. melanogaster CG2577); NP_609851 (D. melanogaster CG7094); NP_608697 (D. melanogaster CG9962); NP_649536 (D. melanogaster CG12147).
Drosophila genetics and genotypes
Request a detailed protocolTransgenic RNAi stocks were obtained from the Vienna Drosophila Resource Center (VDRC; RRID:SCR_013805) (ckIαRNAi: 107574KK; gishRNAi: 108680KK; dcoRNAi: 330069shRNA). ubi-Ex1-468::GFP (wt or S453A) transgenes were cloned using Gateway technology into a modified pKC26-pUbiq plasmid (Gaspar et al., 2015). UAS-CKI transgenes were cloned using Gateway technology into the pUASg-HA(N)-attB vector. UAS-ExFL (wt or S453A) transgenes were cloned into the pUAST-attB plasmid (Bischof et al., 2007) and generation of transgenic flies was performed by BestGene (RRID:SCR_012605). UAS-Ex1-468 (wt or S453A) transgenes were cloned into the pUASg-attB plasmid (Bischof et al., 2013) and transgenic flies were generated in the Crick Fly Facility. Transgenes were inserted at 62E1 (BL-9748) or 28E7 (BL-9723) using ΦC31-mediated integration. gish17 and CG7094F2 mutants were generated by CRISPR-mediated gene editing. gRNA plasmids were injected by the Fly Facility of the Department of Genetics, University of Cambridge. crb82-04 was obtained from Duojia Pan (UT Southwestern). slmb9H4-17 was obtained from Daniel St Johnston (Gurdon Institute, UK). slmb1 was obtained from Daniel Kalderon (Columbia University). dcole88 was obtained from Tomas Dolezal (University of South Bohemia). ckIα8B12 was obtained from Jessica Treisman (NYU Skirball Institute). gishK03891 was obtained from Bloomington (BL-13263).
All crosses were raised at 25°C unless otherwise stated. Genotypes were as follows:
Figure 3A, Figure 3—figure supplement 1A: hsFLP;; FRT82B ubi-RFP, ubi-Ex1-468::GFP/FRT82B crb82-04
Figure 3B, Figure 3—figure supplement 1B, Figure 5—figure supplement 2A–C: hsFLP;; FRT82B ubi-RFP, ubi-Ex1-468::GFP/FRT82B slmb9H4-17
Figure 3C: hsFLP/+; ; FRT82B slmb9H4-17, crb82-04/ubi-Ex1-468::GFP, FRT82B ubi-RFP
Figure 3D, H: w;; hh-Gal4, ubi-Ex1-468::GFP / +
Figure 3E, Figure 3—figure supplement 1C: w;; hh-Gal4, ubi-Ex1-468::GFP/UAS-crbintra
Figure 3F: w;; hh-Gal4, ubi-Ex1-468 S453A::GFP / +
Figure 3G, Figure 3—figure supplement 1D: w;; hh-Gal4, ubi-Ex1-468 S453A::GFP/UAS-crbintra
Figure 3I: w;; hh-Gal4, ubi-Ex1-468::GFP/UAS-HA::ckIα
Figure 3J: w;; hh-Gal4, ubi-Ex1-468::GFP/UAS-HA::gishisoI
Figure 3—figure supplement 1E: w; Act > y+>Gal4 / +; hh-Gal4, ubi-Ex1-468::GFP/UAS-crbintra
Figure 3—figure supplement 1F: w; UAS-lacZRNAi / +; hh-Gal4, UAS-CD8::GFP / +
Figure 3—figure supplement 1G: w; UAS-lacZRNAi / +; hh-Gal4, ubi-Ex1-468::GFP / +
Figure 3—figure supplement 1H: w; UAS-lacZRNAi / +; hh-Gal4, ubi-Ex1-468 S453A::GFP / +
Figure 3—figure supplement 1J: w; en-Gal4, UAS-CD8::GFP/UAS-CD8::GFP (18°C cross)
Figure 3—figure supplement 1K: w; en-Gal4, UAS-CD8::GFP / +; UAS-crbintra / + (18°C cross)
Figure 3—figure supplement 1L: w; en-Gal4, UAS-CD8::GFP/UAS ExWT (18°C cross)
Figure 3—figure supplement 1M: w; en-Gal4, UAS-CD8::GFP, UAS-ExWT / +; UAS-crbintra / + (18°C cross)
Figure 3—figure supplement 1N: w; en-Gal4, UAS-CD8::GFP/UAS-ExS453A (18°C cross)
Figure 3—figure supplement 1O: w; en-Gal4, UAS-CD8::GFP, UAS-ExS453A / +; UAS-crbintra / + (18°C cross)
Figure 5A: hsFLP;; FRT82B ubi-RFP, ubi-Ex1-468::GFP/FRT82B dcole88
Figure 5B: hsFLP;; FRT82B ubi-RFP, ubi-Ex1-468::GFP/FRT82B gish17
Figure 5C: hsFLP, FRT19A ubi-RFP/FRT19A ckIα8B12;; ubi-Ex1-468::GFP / +
Figure 5D: w;; hh-Gal4, UAS-CD8::GFP/UAS-Ex1-468
Figure 5E: hsFLP;; FRT82B ubi-GFP/FRT82B slmb1
Figure 5F: hsFLP;; FRT82B ubi-GFP/FRT82B slmb9H4-17
Figure 5—figure supplement 1A: hsFLP;; FRT82B ubi-RFP, ubi-Ex1-468::GFP/FRT82B gishKG03891
Figure 5—figure supplement 1D: hsFLP; FRT40A ubi-RFP/FRT40A CG7094F2; ubi-Ex1-468::GFP / +
Figure 5—figure supplement 1E: hsFLP, FRT19A ubi-RFP/FRT19A ckIα8B12
Figure 5—figure supplement 1F:, Figure 5—figure supplement 2D–F: hsFLP, FRT19A ubi-RFP/FRT19A ckIα8B12;; ubi-Ex1-468::GFP / +
Figure 5—figure supplement 1H: hsFLP; FRT40A CG7094F2; FRT82B gish17, dcole88/FRT82B ubi-RFP, ubi-Ex1-468::GFP
Figure 5—figure supplement 1I: hsFLP, FRT19A ubi-RFP/FRT19A ckIα8B12;; FRT82B gish17, dcole88/FRT82B ubi-RFP, ubi-Ex1-468::GFP
Figure 6A, B: w; UAS-ckIαRNAi (107574KK) / +; hh-Gal4, ubi-Ex1-468::GFP/tub-Gal80ts
Figure 6C, D: w; UAS-ckIαRNAi (107574KK) /+; hh-Gal4, ubi-Ex1-468::GFP/UAS crbintra, tub-Gal80ts
Figure 6E, F: w; UAS-gishRNAi (108680KK) / +; hh-Gal4, ubi-Ex1-468::GFP/tub-Gal80ts
Figure 6G, H: w; UAS-gishRNAi (108680KK) / +; hh-Gal4, ubi-Ex1-468::GFP/UAS crbintra, tub-Gal80ts
Figure 6—figure supplement 1A: w;; hh-Gal4, ubi-Ex1-468::GFP/UAS crbintra, tub-Gal80ts
Figure 6—figure supplement 1C: UAS-dcoRNAi (330069shRNA) / +; hh-Gal4, ubi-Ex1-468::GFP / +
Figure 6—figure supplement 1D: UAS-dcoRNAi (330069shRNA) / +; hh-Gal4, ubi-Ex1-468::GFP/UAS-crbintra
Figure 6—figure supplement 1E: tub-Gal4, hs-FLP, UAS-nucGFP::myc / + or Y; UAS-Crbintra / +; FRT82B blank/ubi-Ex1-468::mScarlet, FRT82B tub-Gal80
Figure 6—figure supplement 1F: tub-Gal4, hs-FLP, UAS-nucGFP::myc / + or Y; UAS-Crbintra / +; FRT82B gish17/ubi-Ex1-468::mScarlet, FRT82B tub-Gal80
Figure 6—figure supplement 1G: FRT19A blank/tub-Gal80, hs-FLP, FRT19A; UAS-nls-lacZ, UAS-CD8::GFP / +; ubi-Ex1-468::mScarlet, UAS-Crbintra/tub Gal4
Figure 6—figure supplement 1H: ckIα8B12 FRT19A/tub-Gal80, hs-FLP, FRT19A; UAS-nls-lacZ, UAS-CD8::GFP / +; ubi-Ex1-468::mScarlet, UAS-Crbintra/tub Gal4
Figure 7A: ckIα8B12 FRT19A/hsFLP ubi-RFP FRT19A; ex697 (ex-lacZ) / +
Figure 7B: hsFLP / +; ex697 (ex-lacZ) / +; FRT82B gish17/FRT82B ubi-RFP
Figure 7C: ckIα8B12 FRT19A/hsFLP ubi-RFP FRT19A; ; diap1-GFP3.5 / +
Figure 7D: ckIα8B12 FRT19A/hsFLP ubi-RFP FRT19A; yki::GFP / +
Figure 7E: w;; hh-Gal4, UAS-CD8::GFP / +
Figure 7F: w;; hh-Gal4, UAS-CD8::GFP/UAS-ckIα
Figure 7G: w;; hh-Gal4, UAS-CD8::GFP/UAS-gishisoI
Immunofluorescence quantification and statistical analyses
Request a detailed protocolFor quantification of Ex1-468::GFP (wt or S453A) (Figure 3J, Figure 3—figure supplement 1R) or Crb (Figure 3—figure supplement 1Q) ratios in posterior versus anterior compartment, two transverse sections were acquired per disc (A-P; mid-dorsal and mid-ventral pouch) and the pixel intensity of the GFP (Ex) or Cy5 (Crb) signal along the apical region of the cells was measured in the two compartments using Fiji (RRID:SCR_002285). n ≥ 14 for all genotypes; one-way ANOVA with Dunnett’s multiple comparisons test. Quantification of aPKC levels (Figure 5—figure supplement 1G) were performed as above but using transverse sections spanning mutant clones. Data represents 42 clones from 11 wing discs (Figure 5—figure supplement 1G). Significance was calculated by unpaired t-test. For Figure 6—figure supplement 1B, Ex1-468::GFP ratio was calculated as aforementioned and significance was calculated using a two-way ANOVA (comparing all genotypes to Crbintra within each timepoint) with Dunnett’s multiple comparisons test. For Figure 7H, P/A ratio of ex-lacZ intensity was calculated by manually drawing around each compartment of the pouch in maximum intensity projections, then measuring the mean grey pixel value in Fiji. Significance was calculated using a one-way ANOVA comparing all means to hh >control, with correction for multiple comparisons; n ≥ 8 for all genotypes.
Generation of CRISPR/Cas9 mutants
Request a detailed protocolgRNA sequences were as follows: gish AATGGAGCCTATGAAGTCAA; CG7094-up ATATCTCGGACTAAGCATCA; CG7094-down ACGGGGTTGTGAGCCTCAGC. gRNA expression plasmids were created by ligation of annealed oligos into pCFD3 (Addgene 49410) (Port et al., 2014), diluted to 100 ng/μl and injected into nos-Cas9 Drosophila embryos (stock CFD-2; Fly Facility, Department of Genetics, University of Cambridge). Progeny of injected animals were screened for homozygous lethality (gish) or PCR screened to identify a deletion (CG7094; primers F1 tcgtgtgaacatcgtggtcgt and R2 ctttcggttggcagctttgtc). The gish17 mutation was genotyped using primers Gish_PCR_F1 GCGAATGTGTTGCTTTGGTG and Gish_M17_mut2 GTGTAGTTGCGGAGCCTTTC (318 bp amplicon was obtained specifically from mutant allele).
Analysis of genetic interactions in Drosophila adult wings
Request a detailed protocolFor analysis of genetic interactions in the Drosophila wing, flies with the genotypes of interest were collected and preserved in 70% EtOH for at least 24 hr. Wings were removed in 100% isopropanol, mounted in microscope slides using Euparal (Anglian Lepidopterist Supplies) as mounting medium and baked at 65°C for at least 5 hr. Adult wing images were captured using a Pannoramic 250 Flash High Throughput Scanner (3DHISTECH) and extracted using the Pannoramic Viewer software (3DHISTECH). Wing area was quantified using ImageJ (the alula and costal cell of the wing were both excluded from the analysis). Images were processed using Adobe Photoshop (RRID:SCR_014199).
Mass spectrometry analysis
Request a detailed protocolAP-MS experiments followed a GeLC MS/MS approach. Gel lanes were fragmented into eight equally sized pieces and subjected to in-gel trypsin digestion using a Perkin Elmer Janus Automated Workstation. Peptide mixtures were acidified to 0.1% TFA and injected onto a nanoACQUITY UPLC (Waters Corporation) coupled to an LTQ-Orbitap XL (Thermo Fisher Scientific) via an Advion Biosciences Nanomate. Peptides were eluted over a 30 min gradient (5–40% ACN). Mascot distiller was used to extract peak lists, which were searched with Mascot v.2.4.1 (Matrix Science; RRID:SCR_014322) against the Drosophila melanogaster Uniprot reference proteome. Methionine oxidation was entered as a variable modification and search tolerances were 5 ppm and 0.8 Da for peptides and fragments, respectively. Individual lane searches were combined and results compiled in Scaffold 4.0.3 (RRID:SCR_014345).
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files.
References
-
The WW domain protein kibra acts upstream of hippo in DrosophilaDevelopmental Cell 18:309–316.https://doi.org/10.1016/j.devcel.2009.12.013
-
Delineation of a fat tumor suppressor pathwayNature Genetics 38:1142–1150.https://doi.org/10.1038/ng1887
-
Drosophila Schip1 links expanded and Tao-1 to regulate hippo signalingDevelopmental Cell 36:511–524.https://doi.org/10.1016/j.devcel.2016.02.004
-
Phylogeny.fr: robust phylogenetic analysis for the non-specialistNucleic Acids Research 36:W465–W469.https://doi.org/10.1093/nar/gkn180
-
MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research 32:1792–1797.https://doi.org/10.1093/nar/gkh340
-
Mechanical strain regulates the hippo pathway in DrosophilaDevelopment 145:dev159467.https://doi.org/10.1242/dev.159467
-
Upstairs, downstairs: spatial regulation of hippo signallingCurrent Opinion in Cell Biology 51:22–32.https://doi.org/10.1016/j.ceb.2017.10.006
-
Multiprotein complexes governing wnt signal transductionCurrent Opinion in Cell Biology 51:42–49.https://doi.org/10.1016/j.ceb.2017.10.008
-
Sensing the local environment: actin architecture and hippo signallingCurrent Opinion in Cell Biology 31:74–83.https://doi.org/10.1016/j.ceb.2014.09.003
-
Drosophila CK1-γ, gilgamesh, controls PCP-mediated morphogenesis through regulation of vesicle traffickingThe Journal of Cell Biology 196:605–621.https://doi.org/10.1083/jcb.201107137
-
Kibra is a regulator of the salvador/Warts/Hippo signaling networkDevelopmental Cell 18:300–308.https://doi.org/10.1016/j.devcel.2009.12.011
-
The hippo pathway and apico-basal cell polarityBiochemical Journal 436:213–224.https://doi.org/10.1042/BJ20110217
-
The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian hippo pathwaySeminars in Cell & Developmental Biology 23:785–793.https://doi.org/10.1016/j.semcdb.2012.05.004
-
CK1 in developmental signaling: hedgehog and wntCurrent Topics in Developmental Biology 123:303–329.https://doi.org/10.1016/bs.ctdb.2016.09.002
-
Emerging role for epithelial polarity proteins of the crumbs family as potential tumor suppressorsJournal of Biomedicine and Biotechnology 2011:1–9.https://doi.org/10.1155/2011/868217
-
AP-2-complex-mediated endocytosis of Drosophila crumbs regulates polarity by antagonizing stardustJournal of Cell Science 128:4538–4549.https://doi.org/10.1242/jcs.174573
-
The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiationDevelopment 127:1315–1324.
-
Vamana couples fat signaling to the hippo pathwayDevelopmental Cell 39:254–266.https://doi.org/10.1016/j.devcel.2016.09.017
-
The angiomotins--from discovery to functionFEBS Letters 588:2693–2703.https://doi.org/10.1016/j.febslet.2014.02.006
-
Phosphorylation-independent repression of yorkie in Fat-Hippo signalingDevelopmental Biology 335:188–197.https://doi.org/10.1016/j.ydbio.2009.08.026
-
Regulation of the hippo pathway by cell architecture and mechanical signalsSeminars in Cell & Developmental Biology 23:803–811.https://doi.org/10.1016/j.semcdb.2012.06.001
-
DaPKC-dependent phosphorylation of crumbs is required for epithelial cell polarity in DrosophilaThe Journal of Cell Biology 166:549–557.https://doi.org/10.1083/jcb.200311031
-
The β-catenin destruction complexCold Spring Harbor Perspectives in Biology 5:a007898.https://doi.org/10.1101/cshperspect.a007898
-
Localization of hippo signalling complexes and warts activation in vivoNature Communications 6:8402.https://doi.org/10.1038/ncomms9402
-
Casein kinase: the triple meaning of a misnomerBiochemical Journal 460:141–156.https://doi.org/10.1042/BJ20140178
-
The hippo pathway: regulators and regulationsGenes & Development 27:355–371.https://doi.org/10.1101/gad.210773.112
Article and author information
Author details
Funding
Cancer Research UK (C16420/A18066)
- Alexander D Fulford
- Paulo S. Ribeiro
Academy of Medical Sciences (SBF001/1018)
- Alexander D Fulford
- Paulo S. Ribeiro
Wellcome (SBF001/1018)
- Alexander D Fulford
- Paulo S. Ribeiro
Cancer Research UK (FC001175)
- Maxine V Holder
- David Frith
- Ambrosius P Snijders
- Nicolas Tapon
Medical Research Council (FC001175)
- Maxine V Holder
- David Frith
- Ambrosius P Snijders
- Nicolas Tapon
Wellcome (FC001175)
- Maxine V Holder
- David Frith
- Ambrosius P Snijders
- Nicolas Tapon
Wellcome (107885/Z/15/Z)
- Nicolas Tapon
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
We thank the Vienna Drosophila Resource Center for providing transgenic RNAi fly stocks used in this study. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. The antibodies Cq4, E7 and 2A1, respectively developed by E Knust, M Klymkowsky and R Holmgren were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology. We thank M Ditzel, P Meier, B Thompson and Addgene (49410 and 85042) for plasmids and F Pichaud for the Crb-ICD antibody. We thank D St Johnston, D Kalderon, J Treisman, D Pan and T Dolezal for providing fly stocks. We thank Linda Hammond and the Crick Advanced Light Microscopy Facility for assistance with microscopy. We thank the Crick Fly Facility (T Gilbank, S Maloney, C Gillen, S Murray, G Davies and J Kurth) for support with fly husbandry and P Faull for help with Mass Spectrometry. We thank the Crick Genomics Equipment Park for assistance. We thank the Fly Facility at the Department of Genetics, University of Cambridge for help with generation of CRISPR mutants. We thank members of the Ribeiro and Tapon labs for helpful discussions and SA Martin, SA Godinho, JF Marshall and H McNeill for critical reading of the manuscript. The authors declare no conflicts of interest. This work was supported by funding from Cancer Research UK (C16420/A18066) and The Academy of Medical Sciences/Wellcome Trust Springboard Award (SBF001/1018). Work in the Tapon lab is supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001175), the UK Medical Research Council (FC001175), and the Wellcome Trust (FC001175), as well as a Wellcome Trust Investigator award (107885/Z/15/Z).
Copyright
© 2019, Fulford et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,349
- views
-
- 184
- downloads
-
- 14
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
- Developmental Biology
Eukaryotic cells depend on exocytosis to direct intracellularly synthesized material toward the extracellular space or the plasma membrane, so exocytosis constitutes a basic function for cellular homeostasis and communication between cells. The secretory pathway includes biogenesis of secretory granules (SGs), their maturation and fusion with the plasma membrane (exocytosis), resulting in release of SG content to the extracellular space. The larval salivary gland of Drosophila melanogaster is an excellent model for studying exocytosis. This gland synthesizes mucins that are packaged in SGs that sprout from the trans-Golgi network and then undergo a maturation process that involves homotypic fusion, condensation, and acidification. Finally, mature SGs are directed to the apical domain of the plasma membrane with which they fuse, releasing their content into the gland lumen. The exocyst is a hetero-octameric complex that participates in tethering of vesicles to the plasma membrane during constitutive exocytosis. By precise temperature-dependent gradual activation of the Gal4-UAS expression system, we have induced different levels of silencing of exocyst complex subunits, and identified three temporarily distinctive steps of the regulated exocytic pathway where the exocyst is critically required: SG biogenesis, SG maturation, and SG exocytosis. Our results shed light on previously unidentified functions of the exocyst along the exocytic pathway. We propose that the exocyst acts as a general tethering factor in various steps of this cellular process.
-
- Cancer Biology
- Cell Biology
Understanding the cell cycle at the single-cell level is crucial for cellular biology and cancer research. While current methods using fluorescent markers have improved the study of adherent cells, non-adherent cells remain challenging. In this study, we addressed this gap by combining a specialized surface to enhance cell attachment, the FUCCI(CA)2 sensor, an automated image analysis pipeline, and a custom machine learning algorithm. This approach enabled precise measurement of cell cycle phase durations in non-adherent cells. This method was validated in acute myeloid leukemia cell lines NB4 and Kasumi-1, which have unique cell cycle characteristics, and we tested the impact of cell cycle-modulating drugs on NB4 cells. Our cell cycle analysis system, which is also compatible with adherent cells, is fully automated and freely available, providing detailed insights from hundreds of cells under various conditions. This report presents a valuable tool for advancing cancer research and drug development by enabling comprehensive, automated cell cycle analysis in both adherent and non-adherent cells.